Ticker LaunchSPAC · Merger completed
Anzu Special Acquisition Corp I
Business combination with Envoy Medical Corporation
Anzu Special Acquisition Corp I is a blank-check company (SPAC) that raised $420M in its initial public offering on Mar 3, 2021, listing on Nasdaq Capital Market. It completed its business combination with Envoy Medical Corporation on Sep 29, 2023; the combined company is Envoy Medical, Inc. (COCH). BofA Securities led the IPO, with Barclays. Morrison & Foerster advised the SPAC and Davis Polk advised the underwriters on the IPO.
- Status
- Merger completed
- IPO date
- Mar 3, 2021
- IPO size
- $420M
- IPO exchange
- Nasdaq Capital Market
- Target
- Envoy Medical Corporation
- Announced
- Apr 18, 2023
- Closed
- Sep 29, 2023
- Combined company
- Envoy Medical, Inc. (COCH)
- IPO underwriters
- BofA Securities and Barclays
- SPAC counsel (IPO)
- Morrison & Foerster
- Underwriters' counsel (IPO)
- Davis Polk
More on this SPAC for subscribers
- Trust balance and value per share
- Redemptions at each extension and at the merger vote
- Liquidation deadline and extension history
- PIPE and other committed financing
- Merger proxy, registration statement and investor presentation
- Analyst notes from the filings
Every record in the database also has its full filing timeline, a daily-updated calendar, watchlist alerts and Excel export.
Then $99/month or $999/year. Cancel anytime.
Filings
- IPO prospectus (424B4) Mar 3, 2021
- Deal announcement (8-K) Apr 18, 2023
- All filings on EDGAR CIK 1840877
Other deSPACs that closed in 2023
- Falcon's Beyond Global, Inc.via FAST Acquisition Corp. II · closed Oct 5, 2023
- Cheche Group Inc.via Prime Impact Acquisition I · closed Oct 2, 2023
- Estrella Immunopharma, Inc.via TradeUP Acquisition Corp. · closed Sep 29, 2023
- NKGen Biotech, Inc.via Graf Acquisition Corp. IV · closed Sep 29, 2023
- New Nuvinivia Mercato Partners Acquisition Corp · closed Sep 29, 2023
- Conduit Pharmaceuticals Inc.via Murphy Canyon Acquisition Corp. · closed Sep 22, 2023